QHSLab, Inc.
Price data unavailable
Track USAQ in your trading journalAbout QHSLab, Inc.
QHSLab, Inc. (USAQ) is a publicly listed company on US equity markets.
QHSLAB, INC
The company reports trailing twelve-month revenue of $0 and net loss of $103,906.
Key metrics include a return on equity of -6.8%, a debt-to-equity ratio of 0.24.
Use FINOTAUR to track USAQ's price action, review fundamentals, and stay current with company news — all in one research dashboard.
Fundamentals
| Revenue (TTM) | $0 |
| Net Income (TTM) | $-103,906 |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | -6.83% |
| Debt-to-Equity | 0.24 |
| Dividend per Share | — |
Recent News
- GlobeNewswire Inc.·Sep 2
QHSLab (OTCQB: USAQ) Rolls Out Breakthrough Pediatric Screening Tool Linking Allergies and Mental Health
- GlobeNewswire Inc.·May 16
QHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive Growth
- GlobeNewswire Inc.·May 12
Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance
Want real-time analysis on USAQ?
Track it free in your trading journal. Log trades, tag setups, and review your edge.